THE COMPANY
Drugging the Genome
The spark behind NeuBase’s founding, and how the company is drugging the genome with precision genetic medicine.
THE TECHNOLOGY
Advancing a New Class of Medicines
Founder and CEO Dietrich Stephan and CFO Todd Branning talk about the company’s precision genetic medicine technology and pipeline.